journal cover

Prognostication of Poor Survival After Cardiac Resynchronization Therapy

Medicina

Jan 18, 2020

Paulius BašinskasTomas Kazakevičius

Abstract

Background and Objectives: Cardiac resynchronization therapy (CRT) is a successful treatment option for appropriately selected patients. However, one-third of recipients do not experience any positive outcome or their condition even declines. We aimed to assess preimplantation factors a...read more

Mentioned in this Paper

Occlusal Plane
Analysis
Cardiac Resynchronization Therapy
Cessation of Life
Antiplatelet Agents
Laboratory Procedures
Regression Analysis
EEF1A2
Study
Electrocardiographic Monitoring
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Platelet Drugs and Antocoagulants

Antiplatelet drugs decrease platelet aggregation and inhibit thrombus formation while anticoagulants are blood thinners that prolong clotting time. Both agents are amongst the most commonly used medications to reduce coagulation.

Related Papers

Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology

Predictors of response to cardiac resynchronization therapy: A prospective cohort study

Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of CardiologyMay 31, 2017
Ana AbreuBETTER-HF investigators
© 2020 Meta ULC. All rights reserved

Prognostication of Poor Survival After Cardiac Resynchronization Therapy

Medicina

Jan 18, 2020

Paulius BašinskasTomas Kazakevičius

PMID: 31948001

DOI: 10.3390/medicina56010019

Abstract

Background and Objectives: Cardiac resynchronization therapy (CRT) is a successful treatment option for appropriately selected patients. However, one-third of recipients do not experience any positive outcome or their condition even declines. We aimed to assess preimplantation factors a...read more

Mentioned in this Paper

Occlusal Plane
Analysis
Cardiac Resynchronization Therapy
Cessation of Life
Antiplatelet Agents
Laboratory Procedures
Regression Analysis
EEF1A2
Study
Electrocardiographic Monitoring

Similar Papers Found In These Feeds

Platelet Drugs and Antocoagulants

Antiplatelet drugs decrease platelet aggregation and inhibit thrombus formation while anticoagulants are blood thinners that prolong clotting time. Both agents are amongst the most commonly used medications to reduce coagulation.

Related Papers

Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology

Predictors of response to cardiac resynchronization therapy: A prospective cohort study

Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of CardiologyMay 31, 2017
Ana AbreuBETTER-HF investigators
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/prognostication-of-poor-survival-after-cardiac/31948001